The global percutaneous mechanical circulatory support devices market is witnessing rapid expansion due to the rising burden of cardiovascular diseases and advancements in minimally invasive cardiac technologies. These devices play a critical role in stabilizing patients with cardiogenic shock and heart failure by improving cardiac output and maintaining organ perfusion. Increasing adoption in emergency and critical care settings is further driving demand across hospitals and specialized cardiac centers.
Market Overview
The percutaneous mechanical circulatory support devices market was valued at US$ 1,474.28 million in 2019 and is projected to reach US$ 3,964.75 million by 2027; it is expected to grow a ta CAGR of 13.5% during 2020–2027.
The Percutaneous Mechanical Circulatory Support Devices Market Trend is strongly influenced by the growing prevalence of heart failure, technological innovations in ventricular assist devices, and increasing preference for minimally invasive procedures. Additionally, the market is benefiting from rising healthcare expenditure and improved access to advanced cardiac care. Manufacturers are focusing on product development, strategic collaborations, and geographic expansion to strengthen their global footprint.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003194
Market Drivers and Growth Factors
One of the primary drivers of the market is the increasing global geriatric population. Older individuals are more prone to cardiovascular conditions such as heart failure and cardiogenic shock, which significantly boosts the demand for circulatory support devices. Studies indicate that the prevalence of cardiovascular diseases rises sharply with age, creating a strong need for effective treatment solutions.
Furthermore, the rising incidence of lifestyle-related disorders, including hypertension, diabetes, and obesity, is contributing to the growing number of cardiac complications worldwide. These factors collectively increase the demand for advanced treatment options such as percutaneous mechanical circulatory support devices.
Technological advancements are another major growth factor. Innovations in intra-aortic balloon pumps, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices have improved patient outcomes and reduced procedural risks. These improvements are encouraging healthcare providers to adopt such devices more widely.
Segment Analysis
Based on product type, the market is segmented into intra-aortic balloon pumps, VA-extracorporeal membrane oxygenation (ECMO), and short-term ventricular assist devices. Among these, intra-aortic balloon pumps accounted for the largest market share in 2019 due to their widespread use and cost-effectiveness.
However, short-term ventricular assist devices are expected to register the highest growth rate during the forecast period, driven by their superior performance in supporting cardiac function in critical conditions.
By end user, hospitals dominate the market, owing to the availability of advanced infrastructure and skilled healthcare professionals. The hospital segment is also projected to witness the fastest growth, supported by increasing patient admissions for cardiac emergencies and surgeries.
Regional Insights
Geographically, North America holds the largest share of the market due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and early adoption of advanced technologies.
Asia Pacific, on the other hand, is expected to grow at the fastest rate during the forecast period. This growth is attributed to increasing healthcare investments, rising awareness about cardiac care, and a growing patient population in countries such as China and India.
Europe also represents a significant market, supported by favorable reimbursement policies and ongoing research in cardiac support technologies.
Competitive Landscape
The market is highly competitive, with several global players focusing on innovation and expansion strategies. Companies are actively investing in research and development to introduce advanced products and gain a competitive edge. Strategic partnerships, mergers, and acquisitions are also common in this market to enhance product portfolios and market presence.
Top Key Players
- Abbott.
- Medtronic
- Getinge AB
- Teleflex Incorporated
- Livanova Plc (Cardiacassist, Inc.).
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart, Inc.
- CardioBridge GmbH
Future Outlook
The future of the percutaneous mechanical circulatory support devices market looks promising, driven by continuous technological advancements and increasing demand for minimally invasive cardiac procedures. Emerging economies are expected to offer lucrative growth opportunities due to improving healthcare infrastructure and rising awareness about advanced treatment options.
Moreover, ongoing research aimed at enhancing device efficiency and reducing complications will further accelerate market growth. Despite challenges such as high device costs and procedural complexities, the market is poised for substantial expansion in the coming years.
Related Report:
1) Vascular Screening Market Growth, Trends & Demand by 2034
2) Aortic Repair Devices Market Share, Size & Demand by 2034
3) Stromal Vascular Fraction Market Demand, Size & Forecast by 2034
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
